Beyond Vaccines: CDC's ACIP To Look At Antibodies For Respiratory Syncytial Virus Prevention

 
• By Sue Sutter

New maternal/pediatric work group will consider recommendations for use of RSV vaccines and monoclonal antibodies targeting protection of children <18 years. With several products in the late-stage pipeline, group has begun reviewing RSV epidemiology and discussing cost-effectiveness.

Beyond infinity pool
CDC's Advisory Committee on Immunization Practices is looking beyond vaccines to prevent RSV. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers